MAPK1 and non-small cell lung carcinoma: The authors discovered that at a high BPIQ concentration, ERK activation is partially responsible for its antiproliferative activity whereas at a sub-lethal dose of BPIQ, inhibition of ERK occurred that promoted the attenuation of NSCLC migration [21].